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Aortic Aneurysm in Pregnancy
Jennifer Chin and Marguerite Lisa Bartholomew
Abstract
Aortic aneurysms in pregnancy are rare but often fatal due to the natural 
physiologic changes of pregnancy and comorbidities specific to pregnancy, which 
increase the risk for aortic dissection and rupture. These physiologic changes 
are most pronounced in the third trimester and during the peripartum period, 
when approximately one third of dissections occur. In patients with known aortic 
aneurysms or conditions that make them prone to aortic aneurysms, preconcep-
tion counseling can make pregnancy safer and more manageable. Aortic aneu-
rysms diagnosed during pregnancy are usually due to underlying connective tissue 
diseases or aortopathies that have not been previously diagnosed. These women 
require multidisciplinary care including but not limited to obstetrics and gynecol-
ogy, maternal fetal medicine, neonatology, cardiology, cardiothoracic surgery, 
cardiothoracic anesthesia, and genetics. Decisions include screening for dissec-
tion, when to proceed with surgical management, the best mode and timing for 
delivery, postpartum care, and contraception.
Keywords: aortic dissection, pregnancy, postpartum, delivery timing, contraception
1. Introduction
Aortic aneurysms in pregnancy are a rare but potentially fatal occurrence. The inci-
dence in the general population is low at 2.6–3.5 per 100,000 person-years [1]. Women 
present with aortic aneurysms at an average age of 67 years, which is older than the 
average age of men presenting at 60 years. A significant index of suspicion is neces-
sary to identify aortic aneurysms during pregnancy. Symptoms of aortic aneurysm or 
aortic dissection include significant chest pain that may or may not radiate to the back, 
dyspnea, syncope, and dysphagia. Chest x-ray (PA and lateral) should not be withheld 
for pregnant women with such symptoms. Although the cardiac silhouette may appear 
mildly enlarged on chest x-ray during pregnancy, persistent symptoms with or with-
out a widened mediastinum should be evaluated with further imaging. In any patient, 
the highest morbidity and mortality results from an aortic dissection. Table 1 shows 
types of aortic dissections, their description, and their associated mortality rates.
The highest mortality risk is a Stanford type A acute dissection, which describes 
an intimal tear involving the ascending aorta allowing blood to flow into the medial 
layer, which can ultimately culminate in aortic rupture leading to ischemia, tam-
ponade, aortic regurgitation, or stroke. Stanford type A dissections typically pres-
ent with a pulse deficit, systolic blood pressure limb differential of over 20 mmHg, 
focal neurologic deficits, or syncope [2]. Stanford type B dissections, which involve 
the descending aorta, have a lower mortality rate of 10% after 30 days. These are 
usually managed medically with strict blood pressure control as opposed to type A 
dissections, which typically require surgical management [2].
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Risk factors for aortic aneurysms and resulting aortic dissections vary depend-
ing on age. For older women in the general population, hypertension and athero-
sclerosis contribute to the development of aortic aneurysms and aortic dissections. 
In contrast, aortic aneurysms in reproductive aged women usually occur in the 
setting of an underlying connective tissue or genetic disorder, such as Marfan’s 
disease, Ehlers-Danlos syndrome, Turner’s syndrome, or Loeys-Dietz syndrome, or 
an underlying aortopathy, such as bicuspid aorta, coarctation of the aorta, familial 
thoracic aortic dissection syndrome, or aneurysm-osteoarthitis. Among women less 
than 40 years old with aortic aneurysms, pregnancy has been shown to increase the 
risk of dissection by up to 25 fold [1]. Fortunately, the incidence of aortic aneurysm 
in pregnancy is low at 0.05 per 100,000 person-years; however, maternal mortality 
is high and ranges from 21–53% [3]. Aortic dissections in pregnancy account for 
0.1–0.4% of all dissections and represent 0.0004% of all pregnancies [4].
Due to the rare occurrence of aortic aneurysm and dissection in pregnancy, 
management is largely based on case series and expert opinion. Treatment is 
nuanced and complex often due to perceived conflicting priorities of maternal and 
fetal health. The family’s wellbeing is absolutely dependent on maternal survival 
and long-term health so these are not actually separate priorities. This chapter will 
review the unique physiology and risk factors for aortic dissection in pregnant 
women with aortic aneurysms, optimal management of known aortic aneurysms 
in reproductive aged women prior to pregnancy, best practice guidelines for aortic 
aneurysms during pregnancy, mode and timing of delivery of the pregnancy, and 
recommendations for postpartum care including prevention of or planning for 
another high-risk pregnancy.
2. Aortic aneurysm and dissection in pregnancy
2.1 Physiology of pregnancy in aortic aneurysms
Aortic aneurysms in pregnancy have a much higher risk of progression to aortic 
dissection and rupture than aortic aneurysms in the general population. This 
difference is incompletely understood, but can be mostly explained by physiologic, 
specifically vascular, changes unique to pregnancy, as well as underlying connective 
tissue or genetic disorders that predispose reproductive aged women to aortic aneu-
rysms. The clinical features of these diseases are often exacerbated in pregnancy 
and increase the morbidity and mortality of aortic aneurysms in pregnancy and the 
pregnancies themselves.
2.1.1 Vascular changes of pregnancy
During pregnancy, specific physiologic changes occur to support the fetus and 
prepare for childbirth. Cardiovascular changes begin in the first trimester and peak 
in the third trimester and peripartum period, starting at 28 weeks of gestation up 
until 4 weeks after delivery. The vascular changes of pregnancy can negatively 
Type of Dissection Description Mortality
Stanford type A Involves ascending aorta 40%
Stanford type B Involves descending aorta 10%
Table 1. 
Types of aortic dissections and associated mortality rates [1].
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impact the progression of an aortic aneurysm and significantly contribute to the 
increased risk of aortic dissection in aortic aneurysm in pregnancy. Some of these 
changes include increased cardiac output, heart rate, circulating volume, and left 
ventricular mass, all of which increase the risk of aortic dissection and rupture [1]. 
Estrogen and progesterone, both hormones that significantly increase in pregnancy, 
have been proven to change the microstructure of the aortic media and intima 
layers, causing fragmentation of reticulum fibers and loss of corrugation of elastic 
fibers [4]. This weakening of the vessel walls further contributes to the increased 
risk of aortic dissection and rupture. Some hypothesize that the gravid uterus, as it 
increases in size, compresses the aorta and thus increases the aortic outflow resis-
tance, also increasing the risk of aortic dissection [1]. All of these vascular changes 
are most pronounced in the third trimester, when 50% of aortic dissections occur, 
and during the peripartum period, 4 weeks before and 4 weeks after delivery, when 
33% of aortic dissections occur [2]. Certain conditions specific to pregnancy, such 
as pre-eclampsia, which causes vasoconstriction and sudden severe elevation of 
blood pressures, significantly increases the risk for aortic dissection and further 
complicates management.
2.1.2 Connective tissue and genetic disorders in pregnancy
There are several connective tissue and genetic disorders that predispose 
reproductive aged women to aortic aneurysms and have serious implications during 
pregnancy, both on the progression to aortic dissection and rupture as well as the 
pregnancy itself. While not an exhaustive list, the connective tissue and genetic 
disorders that will be discussed in this section include Marfan syndrome, Ehlers-
Danlos syndrome, Loeys-Dietz syndrome, and Turner syndrome.
Marfan syndrome is an autosomal dominant connective tissue disorder that 
affects approximately 3 in 10,000 people [3]. Among pregnant women with aortic 
aneurysms, Marfan syndrome causes approximately half of aortic dissections [1]. 
It is characterized by musculoskeletal abnormalities including pectus excavatum, 
ocular abnormalities, cardiovascular abnormalities including aortic aneurysm and 
dissection, pulmonary abnormalities including spontaneous pneumothorax, skin 
abnormalities including stretch marks, and dura abnormalities including lumbo-
sacral dural ectasia [5]. In the past, life expectancy was extremely limited, usually 
due to cardiovascular complications related to the disease; however, with current 
medical and surgical therapy, life expectancy can extend into the 70s. Diagnosis of 
Marfan syndrome can be made clinically based on criteria within different organ 
systems based on positive or negative family history. In the absence of family 
history, 2 major criteria from 2 different organ systems and 1 other major or minor 
criteria from another organ system must be met. In the presence of family history, 
only 1 major criterion and 1 major or minor criterion from a different organ system 
is necessary for diagnosis. Diagnosis can be confirmed by genetic testing, which will 
show a mutation on the fibrillin gene on chromosome 15.
During pregnancy, women with Marfan disease incur a high risk of morbidity 
and mortality due to the possibility of aortic dissection. This risk is particularly 
pronounced when aortic root dilation is over 4 cm. When the aortic root dilation 
is less than 4 cm, the risk of dissection is 1%; when the aortic root dilation is over 
4 cm, the risk of dissection increases to 10%. Additionally, when aortic root dilation 
is over 4–4.5 cm, pregnant women will likely experience an accelerated rate of aortic 
root growth as compared to nonpregnant women [5]. In addition to maternal cardio-
vascular risk, there is likely an increased risk of obstetric and postpartum com-
plications including a higher rate of preterm labor, preterm premature rupture of 
membranes, maternal urinary incontinence, and pelvic organ prolapse postpartum.
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In nonpregnant patients, beta-blockers significantly slow the growth of the 
aortic root and decrease the risk of aortic dissection. There is some concern about 
the use of these medications in pregnancy due to possible adverse effects for the 
fetus including intrauterine growth restriction and fetal bradycardia. The risk 
benefit ratio supports the use of betablockers for treatment of aortic aneurysm 
during pregnancy. Selective beta-1 receptor blockers, such as metoprolol, are usu-
ally chosen due to a decreased risk of intrauterine growth restriction [5].
Several medications commonly used in obstetrics require careful use in pregnant 
women with Marfan syndrome. In cases of threatened preterm labor, tocolytics 
such as magnesium sulfate and calcium channel blockers can be used without 
significant adverse events. However, beta-adrenergic agonists, such as terbutaline, 
may increase the risk for tachycardia and arrhythmias and thus should be used 
with extreme caution. Additionally, indomethacin, commonly used for tocolysis in 
threatened preterm labor less than 32 weeks of gestation, can cause fluid retention, 
which may increase the risk for aortic dissection, and thus should also be used with 
extreme caution [5].
Ehlers-Danlos syndrome, less common than Marfan syndrome, occurs in 
approximately 1 in 5000 people. There are 6 different types of Ehlers-Danlos 
syndrome, which generally causes hypermobility of the joints, poor wound healing, 
tissue fragility, and hyperelastic skin [3]. The most severe type of Ehlers-Danlos 
syndrome and the most dangerous during pregnancy is the vascular type of disease. 
While hypermobility of the joints and hyperelasticity of the skin are less common 
in this type of disease, there is a significantly increased risk of aortic dissection, 
which is often not preceded by aortic dilation [3]. Due to tissue fragility, pregnant 
women with Ehlers-Danlos syndrome vascular type also have an increased risk of 
peripartum mortality up to 12% due to the risk of arterial or uterine rupture and 
hemorrhage [3].
Loeys-Dietz syndrome is a connective tissue disorder caused by mutation of 
the genes TGFBR1 or TGFBR2. Loeys-Dietz syndrome shares many characteristics 
with Marfan syndrome and Ehlers-Danlos syndrome vascular type. The disease 
is characterized by pectus excavatum, joint hypermobility, arterial tortuosity, 
hypertelorism, and bifid uvula [3]. Life expectancy for women with Loeys-Dietz 
syndrome is short with a mean age of death at 26 years, usually due to vascular 
complications. Similar to Marfan syndrome and Ehlers-Danlos syndrome vascular 
type, tissue fragility contributes to an increased risk of aortic dissection and uterine 
rupture, conferring significant morbidity and mortality in pregnancy.
Turner syndrome is a genetic disorder caused by complete or partial loss 
of one of the X chromosomes in a female. It occurs in approximately 1 in 2000 
female births and is characterized by short stature, delayed puberty, premature 
ovarian failure, learning disabilities, bicuspid aortic valve, coarctation of the 
aorta, and aortic arch abnormalities [3]. Due to the high rate of aortopathy in 
women with Turner syndrome, the risk of aortic dissection in pregnancy is 
significantly elevated over the general population. While most women with 
Turner syndrome experience infertility due to premature ovarian failure, women 
with mosaic Turner syndrome may be fertile and thus capable of pregnancy. The 
risk of death from acute aortic dissection among pregnant women with Turner 
syndrome is 2%, and thus pregnancy is not recommended if a cardiac anomaly is 
present [3].
While knowledge of these connective tissue and genetic disorders may aid in 
diagnosis, aortic dissection may still occur in the absence of known risk factors and 
thus should remain on the differential for any pregnant woman who presents with 
chest pain radiating to her back.
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2.2 Management prior to conception
Screening for aortic aneurysm should ideally be performed prior to conception 
in at-risk women. At-risk women include reproductive aged women with a personal 
or family history of aortic aneurysm or dissection in the past, known connective 
tissue or genetic disorder predisposing them to aortic aneurysm, known aortopathy, 
congenital heart disease, previous cardiac surgery, or significant trauma [4].
Any female with known aortic disease should receive proper family planning 
and contraceptive counseling as soon as and ideally before they are able to become 
pregnant. Important aspects of counseling include the significant risk to maternal 
health and the heritable nature of many underlying diseases that cause aortic aneu-
rysm and dissection. After careful review of a woman’s individual risk or based on 
a woman’s family planning desires, surrogacy and adoption may be the safest route 
for parenthood. Women should be aware that deciding to become pregnant can have 
serious consequences to their own health.
Baseline workup includes referral to and establishment of care with a cardiolo-
gist if not already done, echocardiography, electrocardiogram, and genetic consul-
tation if necessary. Routine medications must be reviewed to make sure they are not 
teratogenic as many patients are stable on warfarin, ACE inhibitors, and ARBs, all 
of which carry significant fetal risk with exposure in utero [4].
Among women with Marfan syndrome, elective surgery is generally recom-
mended prior to conception when the baseline aortic root dilation is greater 
than 4.7 cm [5]. This is due to the maternal risk of death exceeding 10% [4]. 
Preconception care should include echocardiography to assess the proximal and 
distal aortic diameters and valvular and cardiac function. In women with signifi-
cant ventricular enlargement, Holter monitoring is recommended to evaluate for 
arrhythmias.
Elective surgery should also be recommended prior to pregnancy in women with 
bicuspid aortic valve and aortic root dilation greater than 5 cm due to the maternal 
risk of death exceeding 10% [4]. Due to the high risk of aortic dissection, elective 
surgery prior to pregnancy is also recommended in the following situations: history 
of aortic valve surgery and aortic root dilation greater than 4.5 cm, Loeys-Dietz 
syndrome and aortic root dilation greater than 4.2 cm, any aortic root dilation 
greater than 5.5 cm regardless of underlying connective tissue disease, and symp-
tomatic, traumatic, or syphilitic aneurysms [4].
Importantly, while physicians may make recommendations one way or another, 
women have autonomy over when and if they wish to become pregnant and thus 
care teams must be willing to support women’s choices or refer to a team that can 
provide proper clinical care.
2.3 Management during pregnancy
After thorough counseling or if a woman desires pregnancy regardless of the 
risks, management of aortic aneurysm in pregnancy requires close follow up, 
multidisciplinary care, and a heightened index of suspicion for aortic dissection or 
need for surgical intervention.
2.3.1 Screening during pregnancy
After pregnancy is established, strict blood pressure control and serial imag-
ing are necessary to evaluate the aortic root diameter. Depending on the baseline 
aortic root diameter and the underlying cause of aortic aneurysm, imaging can 
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be obtained as frequently as every 4–8 weeks or as infrequently as every trimester 
throughout pregnancy and then postpartum [3]. Blood pressure control and heart 
rate control are recommended using beta-blockers to slow the growth of the aortic 
root and help prevent aortic dissection [5]. Prompt recognition of rapid growth of 
aortic aneurysm or aortic dissection is essential due to the high risk of progression 
to aortic rupture, maternal death, and poor fetal/neonatal outcomes. If the aortic 
root diameter is increasing too rapidly, surgery may be necessary during pregnancy 
to decrease the risk of aortic dissection.
2.3.2 Imaging during pregnancy
Physicians who are unfamiliar with imaging in pregnancy may worry about fetal 
risks with different imaging modalities. Echocardiogram is safe and sufficient to 
monitor stability or progression of known aortic aneurysm in pregnancy. CT or MRI 
should be used to evaluate the aortic arch or thoracic aorta if these areas are known 
or suspected to be involved during pregnancy. In the workup of aortic aneurysm, 
the benefit of an accurate diagnosis from a CT angiogram highly outweighs the 
radiation exposure risk for the maternal-fetal dyad and should not be withheld.  
The radiation exposure from a CT angiogram is 0.01–0.66 mGy, which is well below 
the threshold for fetal injury (50 mGy) [6].
In an acute situation, such as when an aortic dissection is suspected, it is impor-
tant to select the correct and most accurate imaging modality. CT angiography 
imaging is considered the gold standard and accuracy of diagnosis of aortic dis-
section approaches 100% with the newest machines available at most hospitals [7]. 
Transesophageal echocardiography is usually sufficient for diagnosing dissection; 
however, studies have shown significant inter-observer variability. Magnetic reso-
nance angiogram is able to properly evaluate left ventricular dysfunction; however, 
most imaging units refer acute patients to CT angiography due to the time sensitive 
nature of diagnosis of aortic dissection [8].
2.3.3 Surgery during pregnancy
When aortic aneurysm or aortic dissection occurs in pregnancy, management 
is largely based on case series and expert opinion. Withholding indicated surgery 
from a pregnant woman as a result of concern for teratogenesis, pregnancy loss, 
preterm birth, or litigation is unfounded, and may significantly contribute to both 
maternal and neonatal morbidity [9]. Recommendations for aortic aneurysm 
treatment and surgery triage are based on nonpregnant individuals. Table 2 shows 
differing society guidelines for evidence-based timing of surgical intervention. In 
general, if the aortic root diameter exceeds 5 cm, rapid progression in size is noted, 
or there is aortic valve regurgitation, surgical intervention during pregnancy is 
recommended and the benefits absolutely outweigh the risks [3]. While there is no 
standardized definition of rapid progression, most agree that an increase of more 
than 3–5 mm is significant. Pregnant women with aortic aneurysms are more likely 
to have an underlying aortopathy, which should decrease thresholds for surgical 
repair as risk for aortic dissection, aortic rupture, and maternal death are increased. 
Preeclampsia also increases risk for dissection and rupture. Studies have also shown 
an increased risk of mortality for patients with shorter stature, independent of size 
of aneurysm, and thus some experts recommend basing clinical decisions on the 
maximal cross-sectional area, which is calculated by dividing the square centime-
ters of the maximal aortic root diameter by the patient’s height in meters, rather 
than the absolute aortic root diameter. When this measurement is used, surgical 
intervention during pregnancy is recommended if the ratio is above 10 [4].
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Contrary to popular belief, cardiopulmonary bypass (CPB), which is necessary 
for cardiothoracic surgical intervention, is not strictly contraindicated during 
pregnancy. The optimal mode and timing of delivery in relation to cardiothoracic 
surgery is discussed in the next section, but for some women, continuing preg-
nancy during CPB may be considered if they have compelling surgical indications 
and a previable or extremely preterm fetus. During CPB, several modifications can 
improve the fetal mortality rate below 20%, including performing the procedure 
under normothermic conditions in the left lateral decubitus position to maintain 
placental perfusion and decrease the risk of uterine contractions and preterm labor, 
high pump flow rate over 2.5–2.7 L/min−1/m−2 to maintain placental perfusion, 
short CPB and aortic cross-clamp time, perfusion above 70 mmHg, and hematocrit 
over 28% [5, 11].
For some women, particularly in the late second or third trimester, cesarean 
delivery immediately before cardiothoracic surgical intervention is the preferred 
management option. A common misconception in this scenario is excessive uter-
ine bleeding if CPB and full anticoagulation are performed soon after cesarean 
delivery. Post cesarean bleeding is controlled physiologically by myometrial con-
traction and a two-layer suture closure. Preventative and early detection strategies 
include leaving the laparotomy open during the cardiothoracic surgery to directly 
evaluate and manage any intra-abdominal bleeding, placement of a prophylactic 
intrauterine balloon to provide uterine tamponade, or active monitoring of vaginal 
bleeding with the use of Allen stirrups [5]. In a case series, twenty-one mothers 
who had CPB initiated immediately after cesarean delivery had an average blood 
loss of 800 mL. None had excessive bleeding requiring abdominal packing or 
hysterectomy, and none used the additional preventative strategies mentioned 
above [11].
2.3.4 Fetal diagnosis of Aortopathy
Genetic screening or testing of the fetus is recommended for autosomal 
dominant aortopathies due to the high risk of transmission in the offspring. This 
information can be used for delivery and neonatal care planning, such as what 
level of care is needed, or it can be used by parents to determine whether or not to 
continue this particular pregnancy. These conditions include but are not limited to 
Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. This can 
be accomplished by chorionic villus sampling or amniocentesis. Unfortunately, even 
after obtaining fetal or placental cells, diagnosis of Marfan syndrome in the fetus 
Society Recommendation
Canadian society for 
vascular surgery
Aortic root diameter at or above 5 cm, less if growing faster than 10% per year
Japanese circulation 
society
Aortic root diameter at or above 6 cm, 5 cm if accompanied by pain
European society of 
cardiology
Aortic root diameter greater than 5.5 cm, less if there is an indication for surgery on 
the aortic valve to combine surgeries
American college of 
cardiology
Aortic root diameter at or above 5.5 cm, less if growing faster than 0.5 cm/year, 
4-5 cm or maximal cross sectional area greater than 10 with aortopathy or bicuspid 
aortic valve
*Symptomatic patients or patients with aortic dissection require urgent surgical intervention regardless of aortic root 
diameter.
Table 2. 
Society guidelines for surgical intervention of asymptomatic thoracic aortic aneurysms* [3, 10].
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may be missed as there are hundreds of mutations that have been identified on the 
fibrillin 1 gene, and not all of them have been definitely linked to Marfan syndrome 
[7]. Fetal sonographic findings may assist in fetal diagnosis of Marfan syndrome, 
such as cardiomegaly, dilated ascending aorta, dilated pulmonary artery, or dys-
plastic atrioventricular valves [7].
2.4 Mode and timing of delivery
Optimal management for the health of the mother and fetus depends on the 
size of the aortic aneurysm, presence or absence of aortic dissection, presence 
of underlying aortopathy, fetal gestational age, and desires for the pregnancy. 
Multidisciplinary counseling and informed consent are essential and complicated. 
This section will review best practices for the mode of delivery, including assisted 
vaginal or cesarean, and timing of delivery in relation to cardiothoracic surgi-
cal repair.
2.4.1 Mode of delivery
In pregnant women with aortic aneurysms, the mode of delivery depends on the 
presence of aortopathy, size, and stability of the aortic aneurysm. Vaginal delivery 
is recommended for women with aortic root diameters less than 4 cm. Epidural 
for adequate analgesia to help maintain blood pressure and heart rate control is 
recommended. Among pregnant women with Marfan syndrome, dural ectasia, 
or dural sac dilation, should be ruled out prior to epidural placement as they may 
often be asymptomatic in up to 90% of patients with Marfan syndrome [7]. Strict 
blood pressure control with antihypertensive medications and an assisted second 
stage of labor with either vacuum or forceps is recommended to decrease the risk of 
dissection [3].
Cesarean delivery is recommended for women with an aortic root diameter over 
4 cm, severe aortic valve regurgitation, significant progression of aortic aneurysm, 
or history of a previous dissection or repair [7]. Detailed planning and communica-
tion with anesthesia, cardiology, and cardiothoracic surgery are necessary regard-
less of the mode of delivery.
2.4.2 Timing of delivery
Prior to fetal viability, providers must have a discussion with women about the 
option of or recommendation for pregnancy termination. For example, Marfan 
syndrome and other aortopathies with an aortic root size greater than 4 cm is an 
indication for pregnancy termination due to the significant risk of maternal death 
if the pregnancy is continued. If cardiothoracic surgical repair is indicated before 
fetal viability, termination of pregnancy should be strongly considered due to 
the fetal loss rate of up to 33% and the increased potential for long term neuro-
logic impairment after CPB [12]. The definition of fetal viability is nuanced and 
depends on the woman’s personal beliefs, the accuracy of gestational age dating, 
a particular state’s legislation, and institutional guidelines. The American College 
of Obstetricians and Gynecologists defines the periviable period as between 
20 and 25 weeks of gestation. Deliveries under 20 weeks 0 days are defined as 
spontaneous abortions. With accurate gestational age dating, there is no survival 
of neonates delivered at 20 and 21 weeks. Although there have been significant 
advances in neonatal intensive care, individualized and evidence-based conversa-
tions about neonate survival and life without significant neurologic impairment 
are essential.
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After fetal viability, the decision analysis shifts to decisions about CPB and 
cardiac surgery with the fetus remaining in utero or delivery of the fetus just before 
the cardiac surgery. Risks of prematurity include but are not limited to neonatal 
death, low birthweight, respiratory distress, and neuro-developmental disabilities. 
Before 32 weeks of gestation, maternal administration of intravenous magnesium 
sulfate is recommended for fetal neuroprotection to reduce the risk of cerebral 
palsy. Before 34 weeks of gestation, corticosteroids are recommended for fetal lung 
maturation [13]. While there is no consensus, most experts recommend cesarean 
delivery immediately followed by CPB starting at 28–32 weeks of gestation as it 
is thought that at this gestational age, the benefits of delivery without exposure 
to maternal CPB outweigh the risks of neonatal prematurity [4, 5]. Advances in 
neonatal intensive care have improved neonatal survival and a lower gestational age 
for delivery may be reasonable (above 25 weeks) if the patient chooses to avoid the 
fetal risk of CPB and accept the risks of prematurity.
Before approximately 25 weeks of gestation, surgical repair via CPB with a viable 
fetus in utero may be the best management plan. The obstetrician and patient must 
then decide whether to monitor the fetal heart rate during cardiac surgery and what 
actions should be taken in the event of nonreassuring fetal heart rate, such as perfu-
sion adjustments, intrauterine resuscitation, or delivery. This discussion requires 
shared decision making and multidisciplinary planning [5]. If neither urgent 
cesarean delivery nor intrauterine resuscitation are available or desired, intraopera-
tive fetal monitoring is not necessary and may cause more harm than benefit. At all 
time points throughout the surgery, maternal life should be prioritized as maternal 
cardiac arrest or severe hypoxemia will most certainly lead to fetal death or extreme 
fetal morbidity. After 20 weeks gestation during a maternal cardiac arrest, the 
uterus should be emptied by hysterotomy no later than 4–5 minutes after arrest 
to maximize venous return and efficacy of maternal resuscitation efforts. If the 
fetus is viable, delivery no later than 4–5 minutes after maternal cardiac arrest and 
resuscitation also results in good neonatal outcomes. Tocodynamometry, to monitor 
uterine contractions, is generally recommended intraoperatively (when feasible) 
and postoperatively. Preterm contractions are common during and after CPB and 
may or may not result in preterm labor [5].
2.5 Postpartum care
Equally as important as managing acute complications of aortic aneurysm in 
pregnancy is planning for or prevention of the next high-risk pregnancy. This 
section discusses optimization of care in the postpartum period after delivery 
and options for contraception should the patient desire prevention of another 
pregnancy.
2.5.1 Postpartum surveillance
The postpartum period represents a particularly vulnerable timeframe for 
women as many of them will lose insurance coverage, neglect to care for themselves 
due to focus on their newborn, and are recovering from their delivery and poten-
tially cardiothoracic surgery as well. The physiologic changes of pregnancy do not 
immediately return to pre-pregnancy after delivery, and many of the cardiovascular 
changes persist beyond the traditional 6 week postpartum period, when most 
women’s insurance companies will terminate their coverage. In a recent cohort-
crossover study, researchers found that the risk of aortic dissection and rupture 
remain increased as compared to the general population as long as 1 year after 
delivery [14]. This elevated risk of morbidity and mortality emphasizes the need for 
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careful coordination of postpartum care and surveillance, including regular follow 
up with cardiology and obstetrics and gynecology, careful maintenance of medica-
tion, and routine imaging and lab work.
2.5.2 Contraception
The postpartum period is a critical time to discuss contraception and plans for 
childbearing in the future. Unfortunately, due to the medical complexity of these 
patients and the effort required to coordinate care effectively, contraception is often 
forgotten in the care of the recently postpartum woman with an aortic aneurysm or 
aortic dissection during pregnancy. As mentioned earlier in this chapter, the discus-
sion of family planning and contraception has ideally already occurred before or as 
soon as women with known aortic aneurysms are able to become pregnant. If this 
has not occurred, it is beneficial to discuss contraception during the prenatal course 
so that a plan is made for after delivery. If this has not occurred, this discussion 
can happen during the postpartum period. Primary care providers, cardiologists, 
and cardiothoracic surgeons may not be equipped to discuss the safest and most 
reliable contraceptive options with patients, and thus this discussion may be best 
suited for the obstetrician/gynecologist. Ideally, cardiologists and surgeons should 
become familiar with selective contraceptive methods (such as the progestin-only 
injectable) to provide short term so that women with cardiovascular disease do not 
conceive before seeing an obstetrician/gynecologist.
The Centers for Disease Control and Prevention developed the US Medical 
Eligibility Criteria (US MEC) for Contraceptive Use, which gives standardized 
recommendations for each type of contraceptive method in the setting of certain 
medical conditions [15]. In patients with complicated valvular heart disease, 
estrogen containing hormonal contraceptive methods are contraindicated due to 
the increased risk of heart attack and stroke. However, all other methods including 
the copper and levonorgestrel IUDs, the etonogestrel implant, the progestin-only 
injectable, and progestin-only pills, are considered safe and effective for these 
women. Contraceptive counseling should include discussion of a woman’s priori-
ties in different aspects of the contraceptive method, such as efficacy, side effects, 
patient autonomy, and future pregnancy plans.
3. Conclusion
Aortic aneurysm in pregnancy is a rare occurrence that leads to increased mater-
nal, fetal, and neonatal morbidity and mortality. Specific changes to women’s physi-
ology and complications unique to pregnancy predispose pregnant women with 
aortic aneurysm to aortic dissection; therefore a high index of suspicion is lifesav-
ing. Pregnant women with aneurysms are likely to have an underlying collagen dis-
order or aortopathy and are at even higher risk for aortic root diameter growth and 
progression to aortic dissection, rupture, and death. Such underlying conditions 
also increase the risk for poor obstetrical outcomes such as uterine rupture, prema-
ture delivery, and maternal hemorrhage. In women who are known to be at-risk for 
aortic aneurysm or aortic dissection, management and counseling prior to concep-
tion is essential and should include discussion of highly effective contraception, 
surrogacy, and adoption. Management of aortic aneurysm in pregnancy requires 
multidisciplinary care, imaging, and medication management. Indicated surgery 
should not be withheld simply because of the pregnancy or provider discomfort as 
absence of treatment results in worse outcomes. Decisions regarding surgery and 
mode and timing of delivery are nuanced, complicated, and require shared patient 
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centered decision making, effective communication, and cooperation from multiple 
specialists in a tertiary care center. With careful planning, adequate facilities, and 
skilled providers, favorable outcomes for mother and baby are possible for patients 
who experience aortic aneurysm and dissection in pregnancy.
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